214 related articles for article (PubMed ID: 23066312)
1. Serum levels of microRNAs can specifically predict liver injury of chronic hepatitis B.
Zhang H; Li QY; Guo ZZ; Guan Y; Du J; Lu YY; Hu YY; Liu P; Huang S; Su SB
World J Gastroenterol; 2012 Oct; 18(37):5188-96. PubMed ID: 23066312
[TBL] [Abstract][Full Text] [Related]
2. Expression and significance of urinary microRNA in patients with chronic hepatitis B.
Shang JW; Yan XL; Zhang H; Su SB
Medicine (Baltimore); 2019 Sep; 98(37):e17143. PubMed ID: 31517857
[TBL] [Abstract][Full Text] [Related]
3. Profiles of differential expression of circulating microRNAs in hepatitis B virus-positive small hepatocellular carcinoma.
Wang Y; Gao Y; Shi W; Zhai D; Rao Q; Jia X; Liu J; Jiao X; Du Z
Cancer Biomark; 2015; 15(2):171-80. PubMed ID: 25519019
[TBL] [Abstract][Full Text] [Related]
4. Optimisation of quantitative miRNA panels to consolidate the diagnostic surveillance of HBV-related hepatocellular carcinoma.
Tat Trung N; Duong DC; Tong HV; Hien TTT; Hoan PQ; Bang MH; Binh MT; Ky TD; Tung NL; Thinh NT; Sang VV; Thao LTP; Bock CT; Velavan TP; Meyer CG; Song LH; Toan NL
PLoS One; 2018; 13(4):e0196081. PubMed ID: 29672637
[TBL] [Abstract][Full Text] [Related]
5. Plasma miRNA-122-5p and miRNA-151a-3p identified as potential biomarkers for liver injury among CHB patients with PNALT.
Cheng JL; Zhao H; Yang SG; Chen EM; Chen WQ; Li LJ
Hepatol Int; 2018 May; 12(3):277-287. PubMed ID: 29881991
[TBL] [Abstract][Full Text] [Related]
6. Circulating microRNAs in hepatitis B virus-infected patients.
Ji F; Yang B; Peng X; Ding H; You H; Tien P
J Viral Hepat; 2011 Jul; 18(7):e242-51. PubMed ID: 21692939
[TBL] [Abstract][Full Text] [Related]
7. Serum Monounsaturated Triacylglycerol Predicts Steatohepatitis in Patients with Non-alcoholic Fatty Liver Disease and Chronic Hepatitis B.
Yang RX; Hu CX; Sun WL; Pan Q; Shen F; Yang Z; Su Q; Xu GW; Fan JG
Sci Rep; 2017 Sep; 7(1):10517. PubMed ID: 28874844
[TBL] [Abstract][Full Text] [Related]
8. Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies.
Gui J; Tian Y; Wen X; Zhang W; Zhang P; Gao J; Run W; Tian L; Jia X; Gao Y
Clin Sci (Lond); 2011 Mar; 120(5):183-93. PubMed ID: 20815808
[TBL] [Abstract][Full Text] [Related]
9. Expression Profiling of Cellular MicroRNA in Asymptomatic HBsAg Carriers and Chronic Hepatitis B Patients.
Hou X; Liang Y; Chen J; Wei Y; Zeng P; Wang L; Lu C; Diao H
Biomed Res Int; 2017; 2017():6484835. PubMed ID: 28913356
[TBL] [Abstract][Full Text] [Related]
10. Identification of Liver and Plasma microRNAs in Chronic Hepatitis B Virus infection.
Loukachov VV; van Dort KA; Maurer I; Takkenberg RB; de Niet A; Reesink HW; Willemse SB; Kootstra NA
Front Cell Infect Microbiol; 2022; 12():790964. PubMed ID: 35719345
[TBL] [Abstract][Full Text] [Related]
11. A serum microRNA signature is associated with the immune control of chronic hepatitis B virus infection.
Brunetto MR; Cavallone D; Oliveri F; Moriconi F; Colombatto P; Coco B; Ciccorossi P; Rastelli C; Romagnoli V; Cherubini B; Teilum MW; Blondal T; Bonino F
PLoS One; 2014; 9(10):e110782. PubMed ID: 25350115
[TBL] [Abstract][Full Text] [Related]
12. Circulating miR-583 and miR-663 Refer to ZHENG Differentiation in Chronic Hepatitis B.
Zhang H; Guan Y; Lu YY; Hu YY; Huang S; Su SB
Evid Based Complement Alternat Med; 2013; 2013():751341. PubMed ID: 23554832
[TBL] [Abstract][Full Text] [Related]
13. Detection of miR-122 by fluorescence real-time PCR in blood from patients with chronic hepatitis B and C infections.
Ma ZH; Sun CX; Shi H; Fan JH; Song YG; Cong PJ; Kong XM; Hao DL
Cytokine; 2020 Jul; 131():155076. PubMed ID: 32289629
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum microRNA-122/222 levels are potential diagnostic biomarkers in Egyptian patients with chronic hepatitis C but not hepatic cancer.
Motawi TM; Sadik NA; Shaker OG; Ghaleb MH
Tumour Biol; 2016 Jul; 37(7):9865-74. PubMed ID: 26812693
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA profile analysis in the liver fibrotic tissues of chronic hepatitis B patients.
Chen R; Wu JC; Liu T; Qu Y; Lu LG; Xu MY
J Dig Dis; 2017 Feb; 18(2):115-124. PubMed ID: 28127890
[TBL] [Abstract][Full Text] [Related]
16. Serum miR-18a: a potential marker for hepatitis B virus-related hepatocellular carcinoma screening.
Li L; Guo Z; Wang J; Mao Y; Gao Q
Dig Dis Sci; 2012 Nov; 57(11):2910-6. PubMed ID: 22865399
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of miRNA in patients with hepatitis B virus-associated acute-on-chronic liver failure.
Wen Y; Peng SF; Fu L; Fu XY; Wu DX; Liu BJ; Tan DM; Ouyang Y
Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):126-132. PubMed ID: 29602672
[TBL] [Abstract][Full Text] [Related]
18. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma.
Yu F; Lu Z; Chen B; Dong P; Zheng J
Diagn Pathol; 2015 Jul; 10():129. PubMed ID: 26215970
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-194 protects against chronic hepatitis B-related liver damage by promoting hepatocyte growth via ACVR2B.
Gao X; Zhao P; Hu J; Zhu H; Zhang J; Zhou Z; Zhao J; Tang F
J Cell Mol Med; 2018 Sep; 22(9):4534-4544. PubMed ID: 30044042
[TBL] [Abstract][Full Text] [Related]
20. Serum microRNA-125b correlates with hepatitis B viral replication and liver necroinflammation.
Li F; Zhou P; Deng W; Wang J; Mao R; Zhang Y; Li J; Yu J; Yang F; Huang Y; Lu M; Zhang J
Clin Microbiol Infect; 2016 Apr; 22(4):384.e1-384.e10. PubMed ID: 26802212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
